Director, Market Access Strategy, Blueprint Medicines
Chris is the Director of Market Access Strategy at Blueprint Medicines and has 10+ years’ experience in the consulting and life sciences industries. He specializes in the intersections of US market access, drug pricing, and policy reforms. His economic analyses of key policy proposals...
Read More →